Pseudoephedrine Hydrochloride

Producers shown on SFDA

(Record date:15/10/2021）

Producers shown on EP

(Quoted from EP website；record date:15/10/2021）

Producer:Sinopharm Group Xinjiang Pharmaceutical Co., Ltd., established in 1958, has two preparation workshops and two comprehensive extraction workshops meeting GMP standards. It mainly produces 292 varieties and specifications of preparations and APIs in 13 dosage forms, such as large volume injection preparations, small volume injection preparations, tablets, capsules, granules, pills, oral liquids, syrups, mixtures and decoctions.

Staff size:300-399 persons

Registered capital:RMB 90.964 million

Producer:Qinghai Lake Pharmaceutical Co., Ltd., established in 1987, is a professional licorice product manufacturer certified by GMP of the State Food and Drug Administration and CEP of the European food and drug administration. It covers an area of 43558 ㎡ and a building area of 5200 ㎡. At present, the company has set up four factories in Qinghai, Xinjiang, Afghanistan and Uzbekistan. It has an annual production capacity of 50 tons of ephedrine, 300 tons of Ephedra powder, 300 tons of licorice powder and 300 tons of Astragalus powder, as well as other Chinese herbal medicine extraction equipment, and has relatively perfect testing equipment and testing capacity.

Staff size:/

Registered capital:RMB 168.98 million 

Producer:Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. is subordinate to Apeloa Pharmaceutical Co., Ltd. Apeloa Pharmaceutical Co., Ltd. is a state-level key high-tech enterprise and key enterprise in pharmaceutical industry in Zhejiang Province  .The company is engaged in the research and development, production and sales of pharmaceutical products. The main business is in crude drug (API), contract R & D, production service (CDMO) and preparation (FDF) business. 

 In order to improve market competition, our company build core competitiveness continuesly in quality, EHS and technology . Five of the API plants were certified by GMP, four by FDA, three by PMDA, three by CE in EU, one by WHO, one by KFDA, one by Germany GMP, and all of preparation factory were certified by GMP. In addition to the safety and occupational health management system certification, API plants continue to be audited by EHS audits from international pharmaceutical companies or third parties.

Staff size:1000-1999 persons

Registered capital:RMB 83.75 million

Producer:Chifeng Aike Pharmaceutical Technology Co., Ltd. (hereinafter referred to as our company), established in March 2000, is a manufacturer of various APIs and chemical intermediates, a ephedrine manufacturer designated by the State Food and drug administration, and a national high-tech enterprise. At present, it is a member enterprise of Shanghai Pharmaceutical Group Co., Ltd.

The company's products are exported at home and abroad, and its export business covers Europe, Asia, America and other places. The domestic business covers all provinces except Tibet, and the domestic market share of the products is nearly 50%. The company has successively passed the quality audit of international famous pharmaceutical enterprises such as Sino US Stryker, Wyeth Baigong pharmaceutical, Shanghai Squibb and Shanghai Johnson & Johnson pharmaceutical, and has become their stable supplier.

Staff size:200-299 persons

Registered capital:RMB 40.9 million